title: [Risk of intracerebral hematoma and profibrinolytic activity of isotretinoin].
authors.forename: G
authors.initials: G
authors.lastname: Amalfitano
authors.forename: G
authors.initials: G
authors.lastname: Pernod
authors.forename: M
authors.initials: M
authors.lastname: Mallaret
authors.forename: C
authors.initials: C
authors.lastname: Barjhoux
authors.forename: F
authors.initials: F
authors.lastname: Berger
authors.forename: G
authors.initials: G
authors.lastname: Besson
authors.forename: B
authors.initials: B
authors.lastname: Pasquier
mesh_terms: D000328:Adult; D002543:Cerebral Hemorrhage / Q000139:chemically induced*; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects*; D007641:Keratolytic Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D005343:Fibrinolytic Agents; D007641:Keratolytic Agents; D015474:Isotretinoin
vernacular_title: Risque d'hématome intracérébral et activité profibrinolytique de l'isotrétinoïne.